VSTM Verastem Inc

$VSTM This Genfleet patient group was peppered with metastasis and they pulled a bunch of them back. Holy shit guys. GL

$VSTM - strong uptrend chart and 150 & 200 DMA crossing tomorrow which completes the Golden Cross.... chart, fundamentals and projections are all strong BULLS, no need to fret over daily price fluctuation ...

$VSTM not an investment advice , ask AI rNPV buy out probabilities and price target by 2028 yiur self 👇

$VSTM Not sure if this was already posted : In late September 2026, Verastem Oncology received the 2026 Industry Innovator Rare Impact Award from the National Organization for Rare Disorders (NORD). The award was presented by NORD CEO Pamela Gavin to Verastem's leadership team during the week leading up to Rare Cancer Day (which takes place on September 30), to celebrate their innovation and therapeutic advancements for patients with rare ovarian cancer

$VSTM These price targets are insane. This is a huge stock. Buyout price could be in the hundreds. Read the results insane. Keeping people alive with pancreatic cancer and they can take the pill for ever not like chemo. Check back next year.

$VSTM The market sees dilution. I see a syndicate of institutional investors willing to fund VSTM with $250M to accelerate VS-7375. You don't write checks of that size unless you believe the opportunity is far larger than today's valuation. The data attracted capital, not the other way around. 🚀

$VSTM back to double digits, ignoring the haters (saying dirty drug or too much competition in KRAS) CRC signal alone was/is key reason for continued revaluation higher

$VSTM picked some up after hearing about a family friend who is on the trial. After researching the company it sounds extremely bullish on the upside.

$VSTM SI keeps dropping, could easily see a move to 12+ soon before settling in on a tight range until next catalyst. JMHO.

$VSTM I don’t even want BO discussion until we see a $2-3B mkt cap. I don’t see it happening and if it did doesn’t it make more sense to wait until after PH2 for both parties?

$VSTM Verastem has taken all of the financial risks and done all of the heavy lifting. I think we are primed for a buyout, and I have always thought that it would be Lilly. Coincidence or not??? Founder and First CEO of VSTM: Brian Stuglik (former Global Vice President/Global Oncology Marketing for Eli Lilly) Current VSTM Board Member: Brian Stuglik VSTM Combo Trial with: Cetuximab (Eli Lilly) 🤷‍♂️

$VSTM No way!. Not taking it easy on th victory lap, especially after I was bashed for asking about the structure of VSTM drug (seemingly not publically known or revealed at the time). So, I subsequently took it upon myself and spent probably 150 hours combing over several patents - in Chinese!, and scientific articles, then I correctly deduced the structure from thousands of possibilities, then I did computational chemsitry and molecular dynamic simulations and then created a educational video and posted to Youtube for all to see (not a single person could be bothered to leave a comment), then I proceeded to predict the share price, movements and catalysts and news events with unprecendented accuracty - months in advance - something no hedgefund or investment banking firm has ever done, and can't do. And posted all here. Not a single apology. So, yeah, I am rubbing this in many poster's faces.

$VSTM shorts saved for a day by the bad market overall. But they are bleeding and will cover or get liquidated. I'm coming in with more later this week. This is going to $15-20+ soon.

$VSTM I’m no chartist, but it kinda looks like we’re approaching a triple top around 10.5 and then a double at 12.5. Will be interesting to see if we smash through. Revenues make it a decent set up. Let’s ride. GL

$VSTM got 9.73, if 9 holds it can move to 10 break and 10.50 $HIMS has 30 res but if that can break it can go to 32 $IBRX broke to 10.50 off watchlist, I really want 10 to hold now for 10.50 to 11 $IAM new ticker we will watch 20 break for 22.50 to 23 $BMMX also new ticker, we want 3 to hold with volume for 3.50 to 4

$VSTM Where are my bashers from a few months ago? Any apologies? Any kudos for my light years ahead of what multibillion dollar hedge funds wish they could do- predict the stock move up and down in advance and expected news events including overseas that would affect VSTM...and the offering...and the prices... Anybody? Oh yeah...and for free...not trying to get subscribers or newletter members...just posting for kicks....anyone have anything to say?

$VSTM - had this one in September's Playbook (potential setups on radar) but failed to capitalize Congrats to longs 👏

$VSTM early stage for sure but I will not be surprised to see a BO coming, so many big player miss the boat with $RVMD and can’t buy anymore they will be happy to buy a competitor for 5-6 B versus 50B at Rvmd. Still long on $RVMD but like the beat here

$VSTM What a day. Things getting interesting here. Hoping this can hold double digits going forward

$VSTM Ok, I need to do my Board community service. Superintelligence says : The KRAS G12D mutation has been identified in at least 18 different cancer types in the National Cancer Institute's analysis of cancer mutation patterns. The exact count depends on how cancer types and subtypes are classed. Therefore, we’ve got at least 15 to go… Plus, and this is another big one….our Genfleet agreement allows up to three programs, with G12D being the first….so, 2 more molecules in our future We’ve got an existing pipeline that’s kinda jacked and it could go on for a while. Back to regular programming…..